January 25, 2020
International Medical Graduates
The United States Medical Licensing Examination (USMLE®) is a three-step examination for medical licensure in the United States. This is a mandatory examination for American Medical Students, Canadian Medical Students and International Medical Graduates, prior to practicing medicine in the United States of America. The USMLE® is sponsored by the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME).
USLME Step 1
United States Medical Licensing Examination
- USMLE Step 1 assesses whether you understand and can apply important concepts of the sciences basic to the practice of medicine.
- USMLE Step 1 Topics emphaszies principles and mechanisms underlying health, disease, and modes of therapy.
- The USMLE Step 1 ensures mastery of not only the sciences that provide a foundation for the safe and competent practice of medicine, but also the scientific principles required for maintenance of competence through lifelong learning.
- SYSTEM and PROCESS are the two fundamental mandates of the USMLE Step 1 Examination
- Step 1 is a one-day examination divided into seven 60-minute blocks and administered in one 8-hour testing session.
- The number of questions per block on a given examination form will vary, but will not exceed 40.
- The total number of items on the overall examination form will not exceed 280.
USMLE Step 1
- behavioral sciences
- biostatistics and epidemiology
The USMLE Step 1 examination also covers content related to the following interdisciplinary areas:
- molecular and cell biology
SAMPLE USMLE STEP 1 QUESTION
A 32-year-old woman with type 1 diabetes mellitus has had progressive renal failure over the past 2 years. She has not yet started dialysis. Examination shows no abnormalities. Her hemoglobin concentration is 9 g/dL, hematocrit is 28%, and mean corpuscular volume is 94 m3. A blood smear shows normochromic, normocytic cells. Which of the following is the most likely cause?
- A. Acute blood loss
- B. Chronic lymphocytic leukemia
- C. Erythrocyte enzyme deficiency
- D. Erythropoietin deficiency
- E. Immunohemolysis
- F. Microangiopathic hemolysis
- G. Polycythemia vera
- H. Sickle cell disease
- I. Sideroblastic anemia
- J. β-Thalassemia trait
Ace your NAC OSCE!
Enroll with our leading NAC OSCE programming led by experienced Canadian doctors. As of now we full expect the NAC OSCE to occur in September 2020. WE will closely follow any updates from the Medical Council of Canada
Programming starts at $395